COMPARATIVE ESTIMATION OF ANTILITHOGENIC ACTIVITY OF PORCINE KIDNEY DERIVED BIOMEDICAL SUBSTANCE AND SODIUM CITRATE IN EXPERIMENTAL UROLITHIASIS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim to compare the anti-lithogenic activity of biomedical substance derived from freeze-dried porcine kidney and sodium citrate. Materials and methods The experiments were conducted on Wistar rats divided into three groups of 15 animals each: control group (disease control), comparison group (sodium citrate treatment) and experimental group (treatment with biomedical substance from porcine kidneys). Experimental urolithiasis was modeled using the ethylene glycol model. On every 7th day of the 6 week experiment testing was done calcium and oxalate urine concentration and the activity of marker enzymes of renal epithelial damage: lactate dehydrogenase (LDH), γ-glutamyl transferase (GGT), and N-acetyl-β-D-glucosaminidase (NAG). At the end of the experiment, a part of the rats were decapitated and the renal tissue was tested for the oxidant status indicators of (renal thiobarbiturate reactive product content, TBRP, and total prooxidant activity, TPA) and antioxidant enzyme activities: glutathione peroxidase (GPO), superoxide dismutase (SOD) and catalase (CAT). To measure the number and size of calcium deposits formed in the renal papillary area, the Koss histochemical method was used. Results The experimental findings showed developing oxalate nephrolithiasis in the control group, as indicated by urinary supersaturation of oxalate ion, increased activity of marker enzymes, oxidative stress and the formation of numerous calcium deposits in the renal papillary area. In the comparison group, the 3-week use of sodium citrate contributed to a significant decrease in nephrolithiasis: a 3 to 4-fold decrease in the activity of marker enzymes in the urine, a 3.8-fold increase in the concentration of TBRP, normalization of GPO activity; the number and size of urinary calcium deposits decreased by 3.4 and 1.9 times, respectively. In the experimental group, using biomedical substance led to an even greater therapeutic effect. LDH activity and concentration of TPRP showed 1.9 times and by 26.2% greater decrease than in the comparison group, respectively, SOD and CAT activity almost doubled, there were 3.6 times fewer calcium deposits in the field of view and their mean size was 1.7 times smaller than in the comparison group. Conclusion The study findings showed that the porcine kidney derived biomedical substance provide significantly greater antilithogenic effect than sodium citrate.

Full Text

Restricted Access

About the authors

G. V. Pavlyashik

Altai State Medical University of Minzdrav of Russia

Email: ganna1704@mail.r
Research Fellow at the Scientific Research Center for Fundamental Medicine Barnaul, Russia

A. Yu. Zharikov

Altai State Medical University of Minzdrav of Russia

Email: zharikov_a_y@mail.ru
Dr.Biol.Sci., Prof., Head of the Department of Pharmacology Barnaul, Russia

V. I. Kiselev

Altai State Medical University of Minzdrav of Russia

Email: vik@agmu.ru
Corr.-Member of the RAS, Dr.Med.Sci., Prof. at the Department of Normal Physiology Barnaul, Russia

References

  1. Voschula V.I. Kidney stone disease: etiotropic and pathogenetic treatment, prevention / V.I. VoschuIa. Minsk, 2006:268 p.
  2. Bruykhanov V.M., Zharikov A.Yu., Zverev Ya.,F., Lampatov V.V., Azarova O.V., Talalaeva O.S., Motin Yu.G. The experience of application of raw material from pork kidneys in pharmacological correction of experimental nephrolithiasis. Bulletin SB RAMS. 2011 ;31(3):97-103.
  3. Chen D.H., Kaung H.L., Miller C.M. et al. Microarray analysis of changes in renal phenotype in the ethylene glycol rat model of urolithiasis: potential and pitfalls. BJU Int 2004;94(4):637-650.
  4. Khafaziyanova R.Ch., Burykin I.M., Aleeva G.N. Mathematical statistic in experimental and clinical pharmacology. Kazan: Medicine. 2006:374 p.
  5. Evan A.P. Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol 2009; DOI 10.1007/ s00467-009-1116-y.
  6. Rashed T., Menon M., Thamilselvan S. Molecular mechanism of oxalateinduced free radical production and glutathione redox imbalance in renal epithelial cells: effect of antioxidants. Am J Nephrol. 2004;24(5):557568.
  7. Zharikov A.Yu., Motin Y.G., Zverev Y.F., Lampatov V.V., Bryukhanov V.M., Talalaeva O.S. Expression ofrenal crystallization inhibitors in experimental nephrolithiasis. Bulletin of Experimental Biology and Medicine. 2012; 153(2):279-282
  8. Khan S.R., Kok D.J. Modulators of urinary stone formation. Front Biosci; 2004;9:1450-1482

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies